Detall de la convocatòria

Expressió d'interès - Expression of interest

Característiques

Característica
Objectiu de la convocatòria
The ERA4Health Partnership aims to strengthen coordination among European funding organisations to promote transnational research that addresses public health needs. Within this framework, the Trials4Health Joint Transnational Call aims to support randomised, multi-country, investigator-initiated clinical studies designed as pragmatic comparative-effectiveness and/or drug repurposing trials, while promoting transnational collaboration among clinical and public health research teams involved in such studies.
Característiques principals
The focus of the multi-country Investigator-Initiated Clinical Studies is on cardiovascular, metabolic, or autoimmune disorders as primary causes of illness. Proposals should demonstrate high public relevance and target at least one of these diseases, or explore their combination with comorbidities.

Studies should be designed as Phase III randomised interventional trials, either pragmatic comparative-effectiveness or drug repurposing. Comparative-effectiveness trials must assess existing, approved healthcare interventions used in European clinical practice—whether pharmacological or non-pharmacological—while drug repurposing trials should investigate new indications for approved off-patent medicines.
Lloc de presentació
HMRIB and PSMAR staff who need more information should contact:
Research Grants and Contracts Office. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
Carol Barnwell: [email protected] Ext.: 1670
Marta López: [email protected] Ext.: 1576
Convocatòria (URL)
https://era4health.eu/calls/trials4health2026.php
Submission Platform: https://ptoutline.eu/app/trials4health
Informació addicional
This call uses a two-step submission procedure (pre-proposals and full proposals).
  • 13 November 2025 (14:30-16:30 CET) - Webinar Info day and opening of the submission system
  • 30 November 2025 - Deadline for contacting ECRIN representatives (additional budget request)
  • 27 January 2026 (16:00 CET) - Deadline for pre-proposal submission
  • 17 June 2026 (16:00 CET) - Deadline for full proposal submission

    A partner search tool, called PartFinder, is available on the ERA4Health website: https://era4health.eu/calls/partnersearch.php
    • Requisits
  • Applicants may submit only one pre-proposal as coordinator or partner. Double funding is not allowed.
  • Joint research proposals can be submitted by applicants from academia, the clinical/public health sector, enterprises, or operational stakeholders, with partner eligibility subject to national/regional regulations.
  • Consortia must demonstrate adequate expertise and methodological competence to conduct the proposed study.
  • Projects must show clear potential for health, economic, and/or policy impact and highlight the added value of transnational collaboration.
  • Projects must be transnational and include eligible partners from three to five different participating countries, with at least two from different EU Member States or Horizon Europe Associated Countries.
  • The number of countries can be increased to 6 or 7 if Slovakia and/or the Czech Republic are included in the consortium.
  • A consortium can include a maximum of two partners requesting funding from the same country, and up to three collaborators.
  • Each Principal Investigator must ensure that their organisation is eligible for funding by one of the national agencies participating in the call (see Annex I for national rules).
  • PIs must hold a PhD, may participate in only one project proposal per call, and those affiliated with an IIS can apply through their IIS.
  • PIs involved in an ongoing International Collaboration (PCIN) project of the same initiative ending after 31 December 2026 are not eligible unless they serve as coordinator in either the new or ongoing project.
  • A pre-eligibility form is mandatory: PIs must send their CVA-ISCIII form by email before the pre-proposal submission deadline to [email protected].
  • Spanish research groups conducting a clinical trial are strongly encouraged to include a representative from their SCReN or ECRIN-ERIC node in the team.
  • Full proposal applicants selected requesting funding from ISCIII must submit a national application.
    • Dotació
  • Institute of Health Carlos III (ISCIII). Only one eligible partner can request funds to ISCIII per consortium.
    - Up to €750,000 per project if acting as partner
    - Up to €1,000,000 per project if acting as coordinator
  • Department of Health of Catalonia (DS-CAT)
    - Up to €300,000 per project if acting as partner
    - Up to €400,000 per project if acting as coordinator
  • Additional Funding
    An additional budget of up to 15% of the total national/regional budget requested may be used for cross-cutting management activities in collaboration with ECRIN.
    • Durada
    48 months
    AVÍS IMPORTANT
    The call is launched at the European level, but each partner is funded by its own national agency and must comply with the corresponding national rules. Due to the call’s complexity, applicants are strongly advised to contact the Research Grants and Contracts Office early and to carefully review the call text and guidelines before starting their application.

    Arxius

    Arxiu
    ERA4Health_Guideline for Applicants_FV.pdf
    ERA4Health_JTC7 IICS_CallText_FV with Annex.pdf
    Template_Pre-proposal_Trials4Health_FV.docx